StonvexLoading…
StonvexStonvexStonvexCore line items from MASS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.38M | $56.20M | $38.82M | $24.81M |
Operating Income | $-12.88M | $-39.42M | $-42.51M | $-26.19M |
Net Income | $-11.96M | $19.49M | $15.31M | $-13.31M |
EPS (Diluted) | $-0.32 | $0.54 | $0.43 | $0.85 |
Total Assets | $186.69M | $190.07M | $190.87M | $191.70M |
Total Liabilities | $52.52M | $46.37M | $54.57M | $42.88M |
Cash & Equivalents | $67.56M | $70.52M | $62.80M | $61.75M |
Free Cash Flow OCF − CapEx | $1.17M | $-24.64M | $-25.97M | $-21.08M |
Shares Outstanding | 37.41M | 36.32M | 36.12M | 36.06M |